Literature DB >> 8836889

The natural history of hepatitis C: clinical experiences.

R Müller1.   

Abstract

Today's knowledge on the natural history of hepatitis C virus infection derives mainly from local outbreaks and still limited clinical trials. There is a general consensus now that chronic infection occurs in at least 80% of cases after acute disease. Chronic hepatitis C usually runs a mild course with little or no morbidity. In a 15-yr follow-up evaluation of a cohort of 152 women having been infected with HCV-contaminated Rho (D)-immunoglobulin none had developed chronic active hepatitis or cirrhosis. On the other hand, half of 80 patients who started out with more advanced forms of chronic hepatitis C developed cirrhosis over a mean period of 12 yr. Recent observations indicate that progression to severe chronic hepatitis may even occur in HCV-RNA positive individuals with normal aminotransferase activities in serum for long periods. Overall, chronic HCV infection is a slowly progressive disease which often needs histological evaluation, especially in patients with normal biochemical findings.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836889

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia.

Authors:  Mingdong Zhang; Philip S Rosenberg; Deborah L Brown; Liliana Preiss; Barbara A Konkle; M Elaine Eyster; James J Goedert
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

2.  Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort.

Authors:  J McAllister; C Casino; F Davidson; J Power; E Lawlor; P L Yap; P Simmonds; D B Smith
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Evaluation of cross-reactive antibody response to HVR1 in chronic hepatitis C.

Authors:  Bing-Shui Xiu; Xiao-Yan Feng; Jing He; Guo-Hua Wang; Xiang-Ying Zhang; He-Qiu Zhang; Xiao-Guo Song; Kun Chen; Shi-Gan Ling; Cui-Xia Zhu; Lai Wei; Hui-Ying Rao
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

4.  Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C.

Authors:  F Ramalho; A Costa; A Pires; P Cabrita; F Serejo; A P Correia; N Fatela; H Clória; J Lopes; H C Pinto; R Marinho; M Raimundo; J Velosa; A Batista; M C de Moura
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

5.  HLA-Cw*04 and hepatitis C virus persistence.

Authors:  Chloe L Thio; Xiaojiang Gao; James J Goedert; David Vlahov; Kenrad E Nelson; Margaret W Hilgartner; Stephen J O'Brien; Peter Karacki; Jacquie Astemborski; Mary Carrington; David L Thomas
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.

Authors:  H Hinrichsen; G Leimenstoll; G Stegen; H Schrader; U R Fölsch; W E Schmidt
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

7.  Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy.

Authors:  Burkhard J Manfras; Hans Weidenbach; Karl-Heinz Beckh; Peter Kern; Peter Möller; Guido Adler; Thomas Mertens; Bernhard O Boehm
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

Review 8.  Host genetic factors and antiviral immune responses to hepatitis C virus.

Authors:  Chloe L Thio
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

9.  Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1b.

Authors:  Stephanie Jiménez Irausquin; Austin L Hughes
Journal:  Virus Res       Date:  2009-11-06       Impact factor: 3.303

10.  A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.

Authors:  Tao Shen; Xiangmei Chen; Weidong Zhang; Yuanlin Xi; Guanghua Cao; Yuhong Zhi; Shuiwang Wang; Chunhui Xu; Lai Wei; Fengmin Lu; Hui Zhuang
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.